Antibiotic therapy for severe bacterial infections

Area of Science:

• Infectious Diseases
• Pharmacology
• Critical Care Medicine

Background:

• Early antibiotic therapy is vital for severe infections but overuse leads to adverse events and resistance.
• Suboptimal antibiotic use, including in patients without infection, contributes to high mortality and superinfections.
• Antibiotic-induced microbiota changes impact immune and metabolic systems, necessitating treatment optimization.

Purpose of the Study:

• To review evidence and emerging strategies for optimizing antibiotic therapy in severe infections.
• To address controversies in antibiotic selection, de-escalation, and duration.
• To highlight the role of diagnostics and collaborative decision-making.

Main Methods:

• Narrative review of current literature.
• Analysis of factors influencing antibiotic selection.
• Evaluation of emerging diagnostic and therapeutic tools.

Main Results:

• Individualized antibiotic selection using rapid diagnostics and consideration of local factors improves outcomes.
• Rapid de-escalation to narrow-spectrum monotherapy and shortened treatment duration are recommended.
• Pharmacokinetic optimization, therapeutic drug monitoring, and emerging technologies enhance antibiotic stewardship.

Conclusions:

• Optimizing antibiotic therapy requires a multifaceted approach, integrating diagnostics, PK/PD principles, and collaborative care.
• De-escalation and judicious use of antibiotics are key to combating resistance and improving patient outcomes.
• Continued research and technological advancements are essential for personalized and effective antibiotic strategies.